207 related articles for article (PubMed ID: 25578935)
1. Prostate-specific antigen-based population screening for prostate cancer: current status in Japan and future perspective in Asia.
Kitagawa Y; Namiki M
Asian J Androl; 2015; 17(3):475-80. PubMed ID: 25578935
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology of prostate cancer in the Asia-Pacific region.
Baade PD; Youlden DR; Cramb SM; Dunn J; Gardiner RA
Prostate Int; 2013; 1(2):47-58. PubMed ID: 24223402
[TBL] [Abstract][Full Text] [Related]
3. Possible underestimation of the incidence rate of prostate cancer in Japan.
Shimizu H; Ross RK; Bernstein L
Jpn J Cancer Res; 1991 May; 82(5):483-5. PubMed ID: 1905692
[TBL] [Abstract][Full Text] [Related]
4. Deriving benefit of early detection from biomarker-based prognostic models.
Inoue LY; Gulati R; Yu C; Kattan MW; Etzioni R
Biostatistics; 2013 Jan; 14(1):15-27. PubMed ID: 22730510
[TBL] [Abstract][Full Text] [Related]
5. Prostate Cancer Cases Might Rise to 3 Million Globally by 2040.
Harris E
JAMA; 2024 May; 331(20):1698. PubMed ID: 38700857
[No Abstract] [Full Text] [Related]
6. Conditional concordance-assisted learning under matched case-control design for combining biomarkers for population screening.
Li W; Li R; Yan Q; Feng Z; Ning J
Stat Med; 2023 Apr; 42(9):1398-1411. PubMed ID: 36733187
[TBL] [Abstract][Full Text] [Related]
7. Emerging perspectives in prostate cancer: Insights from the 4th Asia Pacific Prostate Cancer Conference.
Mainwaring P; Akaza H
Prostate Int; 2015 Dec; 3(Suppl):S1-4. PubMed ID: 26858943
[No Abstract] [Full Text] [Related]
8. New serum biomarkers for prostate cancer diagnosis.
Chadha KC; Miller A; Nair BB; Schwartz SA; Trump DL; Underwood W
Clin Cancer Investig J; 2014; 3(1):72-79. PubMed ID: 25593898
[TBL] [Abstract][Full Text] [Related]
9. The place of prostate rebiopsy in the diagnosis of prostate cancer.
Vida OÁ; Pricop C; Loghin A; Chiuţu LC; Mártha O
Rom J Morphol Embryol; 2014; 55(3 Suppl):1161-6. PubMed ID: 25607400
[TBL] [Abstract][Full Text] [Related]
10. Clinical performance of serum [-2]proPSA derivatives, %p2PSA and PHI, in the detection and management of prostate cancer.
Huang YQ; Sun T; Zhong WD; Wu CL
Am J Clin Exp Urol; 2014; 2(4):343-50. PubMed ID: 25606581
[TBL] [Abstract][Full Text] [Related]
11. Prostate cancer: diagnostic performance of real-time shear-wave elastography.
Correas JM; Tissier AM; Khairoune A; Vassiliu V; Méjean A; Hélénon O; Memo R; Barr RG
Radiology; 2015 Apr; 275(1):280-9. PubMed ID: 25599156
[TBL] [Abstract][Full Text] [Related]
12. Prostate atypia: does repeat biopsy detect clinically significant prostate cancer?
Dorin RP; Wiener S; Harris CD; Wagner JR
Prostate; 2015 May; 75(7):673-8. PubMed ID: 25597982
[TBL] [Abstract][Full Text] [Related]
13. Emerging biomarkers in the detection and prognosis of prostate cancer.
Filella X; Foj L
Clin Chem Lab Med; 2015 Jun; 53(7):963-73. PubMed ID: 25581761
[TBL] [Abstract][Full Text] [Related]
14. An investigation into the association between DNA damage and dietary fatty acid in men with prostate cancer.
Bishop KS; Erdrich S; Karunasinghe N; Han DY; Zhu S; Jesuthasan A; Ferguson LR
Nutrients; 2015 Jan; 7(1):405-22. PubMed ID: 25580814
[TBL] [Abstract][Full Text] [Related]
15. CE: early localized prostate cancer.
Katz A
Am J Nurs; 2015 Mar; 115(3):34-44; quiz 45-6. PubMed ID: 25674683
[TBL] [Abstract][Full Text] [Related]
16. Bicalutamide 150 mg as secondary hormonal therapy for castration-resistant prostate cancer.
Qian SB; Shen HB; Cao QF; Zhang L; Chen YF; Qi J
Int Urol Nephrol; 2015 Mar; 47(3):479-84. PubMed ID: 25665794
[TBL] [Abstract][Full Text] [Related]
17. Testosterone therapy in men with prostate cancer: literature review, clinical experience, and recommendations.
Morgentaler A; Conners WP
Asian J Androl; 2015; 17(2):206-11. PubMed ID: 25652633
[TBL] [Abstract][Full Text] [Related]
18. PCA3 in prostate cancer and tumor aggressiveness detection on 407 high-risk patients: a National Cancer Institute experience.
Merola R; Tomao L; Antenucci A; Sperduti I; Sentinelli S; Masi S; Mandoj C; Orlandi G; Papalia R; Guaglianone S; Costantini M; Cusumano G; Cigliana G; Ascenzi P; Gallucci M; Conti L
J Exp Clin Cancer Res; 2015 Feb; 34(1):15. PubMed ID: 25651917
[TBL] [Abstract][Full Text] [Related]
19. Dual Inhibition of Cdc7 and Cdk9 by PHA-767491 Suppresses Hepatocarcinoma Synergistically with 5-Fluorouracil.
Li W; Zhao XL; Shang SQ; Shen HQ; Chen X
Curr Cancer Drug Targets; 2015; 15(3):196-204. PubMed ID: 25643258
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
